SLC1A5 expression was higher in moderately/poorly differentiated OSCC or TCGA-HNSCC tumors than well-differentiated counterparts (Figs. 1L and S1L, respectively), suggesting that glutamine uptake might have been more demanded in tumors exhibiting less squamous differentiation. The gene discussed is SLC1A5; the disease is head and neck squamous cell carcinoma.